Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 264 results found. Search for [ COVID-19 vaccine China trials ]

Results 1 to 21 of 264
Reuters
April 12, 2021
The currently available vaccines \"don't have very high rates of protection\", said Gao Fu, the director of the Chinese Centers for Disease Control and Prevention


BusinessToday.In
March 19, 2021
Stelis and the RDIF plan to start supplying the vaccine doses in the third quarter of this year, said Strides Pharma. It is yet to be ascertained which countries the doses would go to


Reuters
March 16, 2021
The moves by some of Europe's largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca's


PTI
March 14, 2021
After holding the first Leaders' Summit of Quadrilateral alliance on Friday, Prime Minister Narendra Modi, US President Joe Biden, Australian PM Scott Morrison and Japanese PM Yoshihide Suga wrote a opinion piece in The Washington Post


Associated Press
March 13, 2021
Although emergency vaccinations have been underway in China since at least last summer, the country has been slow to announce whether it had any plans to achieve herd immunity


Reuters
March 10, 2021
The US company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial. That has kept its vaccine, developed with Germany's BioNTech SE, out of one of the world's biggest drug markets


Rashi Bisaria
New Delhi, March 10, 2021
Covaxin safe, immunogenic with no side effects, says Lancet Medical peer-review journal Lancet has published the interim results for phase 2 trials of Bharat Biotech's COVID-19 vaccine, Covaxin, calling it 'safe, immunogenic with no serious side effects'. The double-blind, randomised, multicentre, phase 2 clinical trial to evaluate the immunogenicity and safety of Covaxin (BBV152) in healthy adults and adolescents (aged 12-65 years) was carried out at nine hospitals in India. Data breach c...


Associated Press
March 10, 2021
Sputnik V has not yet been approved for use in the EU, but the body's regulator, the European Medicines Agency, started a rolling review of the vaccine last week


PTI
February 28, 2021
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator


BusinessToday.In
February 24, 2021
Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week


Reuters
February 14, 2021
In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data


BusinessToday.In
New Delhi, February 3, 2021
Russia's COVID-19 vaccine, Sputnik V, has shown 91.6 per cent efficacy in phase 3 trials with no serious side effects, as per an interim analysis published in The Lancet Journal; Oxford Languages has named 'Aatmanirbharta' as its Hindi Word of the Year 2020; Alibaba Group founder Jack Ma has been delisted from \"Chinese entrepreneurial leaders\" list published by the country's official state media. Watch this and more on News Blast. Also Read: RBI releases framework for risk-based internal audit of NBFCs, UCBs


BusinessToday.In
February 2, 2021
The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors - recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).


Reuters
February 2, 2021
The firm obtained rights to supply the AZD1222 vaccine, developed by the Anglo-Swedish drugmaker and Oxford University, in mainland China last year in return for having capacity to produce at least 200 million doses by the end of 2021


Reuters
January 30, 2021
The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI's links to the People's Liberation Army (PLA) include research with China's top military supercomputing experts


BusinessToday.In
January 27, 2021
The Reliance Group will purchase hundreds of COVID-19 breath testing system from the Israeli company for $15 million. The group will use them to conduct millions of tests at a cost of $10 million per month


PB Jayakumar
January 27, 2021
COVID-19 vaccine: About 19 vaccines are going to be globally available in the coming few weeks and months. Of this, about nine have already got emergency use authorisation


Reuters
January 17, 2021
COVID-19 vaccine: Pakistan, which is seeing rising numbers of coronavirus infections, said its vaccines would be procured from multiple sources


BusinessToday.In
January 12, 2021
Among these vaccines are those developed by Zydus Cadila, Biological E and Gennova, along with Russia's Sputnik-V vaccine


BusinessToday.In
January 12, 2021
Stocks to watch today on January 12:  GAIL, Tata Motors, Dr Reddy, M&M, HUL, Force Motors, Sunteck Realty among others are the top stocks to watch out for in Tuesday's trading session


PAGES 1 OF 14  12345